PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Fann WE, Janowsky DS, Davis JM, Oates JA. Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) ii, 436-7 [868]
Fann WE. J Clin Pharmacol. Oct 1973; 13(10): 388-90 Pubmed [813]
Fanoe S. Br J Clin Pharmacol. Feb 2009; 67(2): 172-9 Pubmed, Volltext, DOI [9583]
Fanos V. Drug Saf. Mar 1999; 20(3): 245-67 Pubmed [5367]
Fanos V. J Chemother. Oct 2001; 13(5): 461-72 Pubmed [5368]
Fanouriakis A. Ann Rheum Dis. Jun 2019; 78(6): 736-745 Pubmed [8881]
Faraj P. EBioMedicine. Sep 2023; 95: 104779 Pubmed [14111]
Farenc C. J Clin Pharmacol. Jan 2001; 41(1): 44-50 Pubmed [11152]
Farhangi V. Int J Psychiatry Med. Jan 2003; 33(2): 201-2 Pubmed [1749]
Farhat NM. Am J Health Syst Pharm. Jan 2016; 73(2): 56-9 Pubmed [6972]
Farhoudi M. Expert Opin Drug Metab Toxicol. Apr 2015; 11(4): 471-9 Pubmed [8725]
Faria JV. Bioorg Med Chem. Nov 2017; 25(21): 5891-5903 Pubmed [8443]
Fariello RG. Neurotherapeutics. Jan 2007; 4(1): 110-6 Pubmed [12270]
Farlow MR. Clin Pharmacokinet. Jan 2003; 42(15): 1383-92 Pubmed [8003]
Farlow MR. Curr Med Res Opin. Feb 2010; 26(2): 263-9 Pubmed [9933]
Farnier M. Expert Rev Cardiovasc Ther. May 2012; 10(5): 565-75 Pubmed [3958]
Farokhnia M. Psychopharmacology (Berl). Feb 2014; 231(3): 533-42 Pubmed [11517]
Faron-Górecka A. Brain Res. Aug 2004; 1016(2): 263-7 Pubmed [2728]
Farquharson CA. Heart. Nov 2002; 88(5): 475-80 Pubmed [10806]
Farshidi H. Trials. Mar 2025; 26(1): 108 Pubmed [14229]
Faruquee CF. Pak J Pharm Sci. Apr 2010; 23(2): 143-8 Pubmed [5188]
Fasipe OJ. IBRO Rep. Jan 2019; 6: 95-110 Pubmed, Volltext, DOI [9875]
Faskowitz AJ. Cell Mol Neurobiol. May 2013; 33(4): 537-42 Pubmed [12986]
Fattinger K. Eur J Clin Pharmacol. Feb 2002; 57(12): 863-7 Pubmed [11826]
Faucette SR. Drug Metab Dispos. Mar 2004; 32(3): 348-58 Pubmed [425]
Faucette SR. Drug Metab Dispos. Oct 2000; 28(10): 1222-30 Pubmed [67]
Fauchier JP. Arch Mal Coeur Vaiss. May 1993; 86(5 Suppl): 757-67 Pubmed [8804]
Fava M. Int Clin Psychopharmacol. Nov 2018; 33(6): 312-321 Pubmed, Volltext, DOI [10147]
Fava M. Prim Care Companion J Clin Psychiatry. Jan 2005; 7(3): 106-13 Pubmed [14408]
Favale E. Seizure. Jul 2003; 12(5): 316-8 Pubmed [10623]
Fawcett RG. Erythema multiforme major in a patient treated with carbamazepine. J Clin Psychiatry (1887) 48, 416-17 [845]
Fayssoil A. Ann Cardiol Angeiol (Paris). Jun 2011; 60(3): 165-8 Pubmed [3554]
Fazel Y. Expert Opin Drug Saf. Aug 2015; 14(8): 1317-26 Pubmed [6962]
Fazzi P. Am J Respir Med. Jan 2003; 2(4): 311-20 Pubmed [8875]
FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod). U.S. Food and Drug Administration (FDA). Stand Dec 2017. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-revised-recommendations-cardiovascular-monitoring-and-use-multiple [10020]
FDA Stand: 17.02.2016 [25]
Feder A. Am J Psychiatry. Feb 2021; 178(2): 193-202 Pubmed [12416]
Feder. J Clin Psychiatry (1991) 52, 163-164 [1349]
Federico S. Clin Pharmacokinet. Jan 2006; 45(2): 169-75 Pubmed [5671]
Fedgchin M. Int J Neuropsychopharmacol. Oct 2019; 22(10): 616-630 Pubmed [12068]
Fee JPH, et al. Clin Pharmacol Ther (1987) 41, 80-4 [1862]
Feely J. N Engl J Med. Mar 1981; 304(12): 692-5 Pubmed [4152]
Feierman DE. Drug Metab Dispos. Sep 1996; 24(9): 932-9 Pubmed [4702]
Feigenson JS. Neurology. May 1976; 26(5): 430-3 Pubmed [10435]
Feiger AD. CNS Spectr. Jan 2009; 14(1): 41-50 Pubmed [12605]
Feighner JP. J Clin Psychiatry. Jun 1990; 51(6): 222-5 Pubmed [1393]
Fein S. Am J Psychiatry. Feb 1988; 145(2): 249-50 Pubmed [1741]
Feinberg SS. J Clin Psychiatry. Nov 2004; 65(11): 1520-4 Pubmed [2368]
Fekete S. Pharmacopsychiatry. May 2021; 54(3): 117-125 Pubmed [10907]
Feld JJ. Liver Int. Jan 2017; 37(1): 5-18 Pubmed, Volltext, DOI [7904]
Feldman et al. J Pharm Clin (1995) 14, 296-297 [1489]
Feldman M. Int J Neurosci. Jun 2021; : 1-12 Pubmed [12193]
Feldman RG. JAMA. Dec 1976; 236(23): 2603 Pubmed [2191]
Feldman SA. Br Med J. May 1970; 2(5705): 336-8 Pubmed, Volltext [1284]
Fell et al. Eur J Clin Pharmacol (1973) 5, 166-173 [1840]
Felmlee MA. AAPS J. Jan 2021; 23(1): 22 Pubmed [12698]
Felthous AR. Pharmacotherapy. Apr 2010; 30(4): 145e-50e Pubmed [12945]
Fendrich Z. Cas Lek Cesk. Jul 2000; 139(14): 440-4 Pubmed [8564]
Feng HP. Antimicrob Agents Chemother. Feb 2019 Pubmed [6524]
Feng HP. Clin Pharmacol Drug Dev. Jun 2019 Pubmed [7883]
Feng HP. Clin Transl Sci. Nov 2018; 11(6): 553-561 Pubmed, Volltext, DOI [6577]
Feng HP. Clin Transl Sci. Nov 2018; 11(6): 562-572 Pubmed, Volltext, DOI [6575]
Feng HP. Clin Transl Sci. Sep 2017; 10(5): 360-365 Pubmed, Volltext, DOI [6572]
Feng HP. J Antimicrob Chemother. Mar 2019; 74(3): 710-717 Pubmed [6574]
Feng HP. J Clin Pharmacol. May 2018; 58(5): 666-673 Pubmed [6578]
Feng J. Front Microbiol. May 2016; 7: 743 Pubmed, Volltext, DOI [7970]
Feng M. J Psychopharmacol. Apr 2017; 31(4): 474-486 Pubmed [5085]
Feng P. Chem Biol Interact. Sep 2018; 293: 115-123 Pubmed [8418]
Feng PF. Mol Pharm. Apr 2019; 16(4): 1477-1488 Pubmed [12705]
Feng X. PLoS One. Jan 2018; 13(1): e0190798 Pubmed, Volltext, DOI [8450]
Feng XQ. J Pain Res. May 2017; 10: 1225-1239 Pubmed, Volltext, DOI [4584]
Feng Z. J Int Med Res. Feb 2013; 41(1): 239-43 Pubmed [7023]
Fenoglio JJ Jr. Hum Pathol. Oct 1981; 12(10): 900-7 Pubmed [2147]
Fenster P. Clin Pharmacol Ther. Apr 1980; 27(4): 450-3 Pubmed [4182]
Fenster PE. Pharmacotherapy. Jan 1986; 6(1): 1-9 Pubmed [13762]
Feret BM. Ann Pharmacother. Apr 2000; 34(4): 483-6 Pubmed [12582]
Fernandes C. Mov Disord. Mar 2011; 26(4): 766-7 Pubmed [9399]
Fernandes E. Int J Mol Sci. Oct 2018; 19(11) Pubmed, Volltext, DOI [8371]
Fernandes FM. PLoS One. Jun 2018; 13(6): e0199028 Pubmed, Volltext, DOI [9610]
Fernandes LC. J Clin Psychopharmacol. Jun 2002; 22(3): 326-9 Pubmed [2805]
Fernandez de Gatta MR. Ther Drug Monit. Jan 1986; 8(4): 416-20 Pubmed [2452]
Fernandez-Abascal J. Int J Mol Sci. Oct 2018; 19(11) Pubmed, Volltext, DOI [10464]
Fernandez-Fernandez B. AIDS Res Treat. Jan 2011; 2011: 354908 Pubmed, Volltext, DOI [5698]
Ferrari A. Pharmacol Res. Dec 2004; 50(6): 551-9 Pubmed [10857]
Ferrari S. Life Sci. Jan 1991; 48(23): 2259-65 Pubmed [5003]
Ferrari SL. Transplantation. Sep 1994; 58(6): 725-7 Pubmed [6042]
Ferraris O. Antiviral Res. Jun 2015; 118: 75-81 Pubmed [8665]
Ferreira F. Eur J Case Rep Intern Med. Jan 2016; 3(2): 000341 Pubmed [11308]
Ferreira JJ. Eur J Neurol. May 2015; 22(5): 815-25, e56 Pubmed [12205]
Ferreira JJ. Lancet Neurol. Feb 2016; 15(2): 154-165 Pubmed [12204]
Ferri N. Pharmacol Res. Sep 2016; 111: 592-599 Pubmed [8515]
Ferro Desideri L. Pharmaceutics. May 2023; 15(5) Pubmed [13350]
Ferry FR. Rev Inst Med Trop Sao Paulo. May 2014; 56(3): 265-6 Pubmed, Volltext, DOI [6446]
Ferry JJ. J Acquir Immune Defic Syndr Hum Retrovirol. Jul 1998; 18(3): 252-9 Pubmed [6906]
Fessel J. Alzheimers Dement (N Y). Nov 2019; 5: 780-788 Pubmed [11451]
Fessler D. Pain Physician. Nov 2012; 15(6): 489-93 Pubmed [6464]
Fetzer J, Kader G, Danaby S. Lithium encephalopathy: a clinical, psychiatric, and EEG evaluation. Am J Psychiatry (1981) 138, 1622-3 [896]
Fezolinetant. Gelbe Liste. Stand May 2024. https://www.gelbe-liste.de/wirkstoffe/Fezolinetant_56955 [13644]
Fichtenbaum CJ. Clin Pharmacokinet. Jan 2002; 41(14): 1195-211 Pubmed [10205]
Fidecka S. Pol J Pharmacol Pharm. Jan 1989; 41(1): 23-32 Pubmed [5167]